Currently Viewing:
American Psychiatric Association 2019 Annual Meeting
Dr David Kingdon on the Principles Underlying the Use of CBT in Psychosis
May 19, 2019
Dr Jonathan Avery on the Dangers of Misdiagnosing or Mistreating Concurrent Psychiatric and Substance Use Disorders
May 19, 2019
Studies Reveal Loneliness, Trauma Effects Among Minority Urban Women
May 20, 2019
Hochschild Gives Psychiatrists a View of Bridging the Political Chasm
May 20, 2019
Dr Lori Raney Outlines the Advantages and Limitations of Treating Mental Health Disorders in Primary Care Settings
May 20, 2019
Dr Steven Adelsheim Discusses Changing Stigmas Around Mental Illness in Young People
May 20, 2019
Dr Jacob Ballon: Coordinated Teams, Collaboration Are Key to Supporting People With Psychosis
May 21, 2019
TRANSFORM-2 Results on Esketamine Published, Along With Caveats
May 21, 2019
Poll Finds Most Workers Can Get Mental Health Care, but a Third Worry About Seeking It
May 21, 2019
Adam Simmons on Patient Preferences When Taking Antipsychotic Medications
May 21, 2019
Alkermes' Novel Schizophrenia Drug Shows Less Weight Gain, Addressing Top Patient Complaint
May 21, 2019
Where Culture and Science Collide: How Ethnic, Social Factors Affect Response to Psychotropic Drugs
May 22, 2019
Currently Reading
Dr Godfrey Pearlson on the Merits of Using Biological Measures to Classify Psychiatric Diseases
May 23, 2019
Dr King Davis Explains the Privacy Dangers of Digitizing Archives, Including Psychiatric Records
May 24, 2019
Dr David Kingdon Discusses How CBT Techniques Tailored to Psychosis Can Help Patients Feel Understood
May 30, 2019
Dr Jonathan Avery Discusses Causes and Consequences of Concurrent Mental Illness and Substance Use Disorders
May 31, 2019
Adam Simmons Outlines Efficacy of ALKS 3831 Across Subgroups of Patients With Schizophrenia
June 11, 2019
Dr Lori Raney Defines Integrated, Collaborative Care for Behavioral Health
June 13, 2019
Dr David Kingdon Describes How CBT Can Fit Into a Psychosis Treatment Plan
June 17, 2019
Dr Steven Adelsheim Discusses the Importance of Early Diagnosis for Young People With Psychosis
June 20, 2019
Dr Isaac Galatzer-Levy Explains the Importance of Accurately Predicting PTSD After a Traumatic Event
June 22, 2019
Dr Jonathan Avery Explains How Substance Use Affects the Care of Patients With Mental Illness
June 23, 2019
Dr David Kingdon on the Factors Predicting CBT Success in Psychosis
June 25, 2019
Adam Simmons Explains the Importance of Finding New Treatment Options for Schizophrenia
June 29, 2019

Dr Godfrey Pearlson on the Merits of Using Biological Measures to Classify Psychiatric Diseases

Current diagnostic tools, such as the Diagnostic and Statistical Manual of Mental Disorders, rely on symptoms to diagnose psychiatric diseases, but using biological measures instead could provide a more reliable, valid method of classifying these syndromes, said Godfrey Pearlson, MD, professor of psychiatry and neuroscience, Yale School of Medicine.


Current diagnostic tools, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM), rely on symptoms to diagnose psychiatric diseases, but using biological measures instead could provide a more reliable, valid method of classifying these syndromes, said Godfrey Pearlson, MD, professor of psychiatry and neuroscience, Yale School of Medicine.

Transcript

What are the advantages of using biologic measures to classify disease instead of the clinical DSM diagnoses?

Clinical DSM diagnoses are based on phenomenology, that is, what we observe in terms of patients’ symptoms and their clinical course. That’s basically where the rest of medicine was in the 17th and 18th century, before we could identify actual diseases where we knew their underlying cause, their etiology. If you rely only on symptoms, then you have something that’s akin to having fevers or dropsy or cough, where you have just a loose syndrome that everyone can agree on reliably but there’s no underlying validity. So if you just have people who are coughing up blood in medicine, then they could have pneumonia or lung cancer or severe asthma or a really bad cold, and there’s no way to sort them out without underlying biological measures.

So that’s pretty much where we are, I think, in psychiatry at the moment. Biology’s a reliable, valid method for potentially reclassifying these loose syndromes, figuring out what’s under the hood as far as biology, and that once we understand the origin of the illness and what’s wrong with the person biologically at a brain level, then we can move closer towards finding treatments that are individualized.

What are the consequences of the overlap in the current conditions encompassing psychosis in current diagnostic tools like the DSM?

Basically that we’re sort of groping around in the dark when it comes to defining illnesses. As I tried to suggest, it’s where medicine was in the 18th century before we understood what caused diseases. So before we had stethoscopes or otoscopes to look in people’s ears, we really couldn’t see what was going on and try and take measurements, even a basic measurement like temperature. Once you have reliable biological tools, it gives you an insight into what’s going on. Symptoms alone don’t really do that, cause symptoms overlap horribly all the way through medicine.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up